Tianjin Chase Sun Pharmaceutical Co Ltd Strategic Asset Allocation Index
Tianjin Chase Sun Pharmaceutical Co Ltd strategic asset allocation index. Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Strategic Asset Allocation Index of 38.0% as of June 2023. Strategic assets (PP&E of CN¥3.31 Billion plus long-term investments of CN¥-) total CN¥3.31 Billion, measured against net assets of CN¥8.72 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Tianjin Chase Sun Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2021)
Strategic asset allocation index of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2021. This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2006 to 2021. As of June 2023, the index stands at 38.0%, representing strategic assets of CN¥3.31 Billion against net assets of CN¥8.72 Billion CNY. Check 300026 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Tianjin Chase Sun Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2006–2021)
Tianjin Chase Sun Pharmaceutical Co Ltd strategic asset allocation index by year from 2006 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2021, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Tianjin Chase Sun Pharmaceutical Co Ltd (300026) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 36.5% | CN¥2.90 Billion | CN¥2.90 Billion | CN¥- | CN¥7.95 Billion | ▲ +1.9 pp |
| 2020 | 34.6% | CN¥2.56 Billion | CN¥2.56 Billion | CN¥- | CN¥7.39 Billion | ▲ +2.0 pp |
| 2019 | 32.6% | CN¥2.31 Billion | CN¥2.31 Billion | CN¥- | CN¥7.07 Billion | ▲ +0.9 pp |
| 2018 | 31.7% | CN¥2.08 Billion | CN¥1.80 Billion | CN¥281.52 Million | CN¥6.58 Billion | ▲ +3.3 pp |
| 2017 | 28.4% | CN¥1.85 Billion | CN¥1.58 Billion | CN¥273.62 Million | CN¥6.51 Billion | ▲ +1.8 pp |
| 2016 | 26.7% | CN¥1.61 Billion | CN¥1.37 Billion | CN¥235.55 Million | CN¥6.04 Billion | ▲ +4.6 pp |
| 2015 | 22.1% | CN¥1.17 Billion | CN¥1.13 Billion | CN¥43.16 Million | CN¥5.29 Billion | ▼ -9.7 pp |
| 2014 | 31.8% | CN¥749.15 Million | CN¥749.15 Million | CN¥- | CN¥2.36 Billion | ▼ -11.2 pp |
| 2013 | 42.9% | CN¥731.17 Million | CN¥731.17 Million | CN¥- | CN¥1.70 Billion | ▼ -7.7 pp |
| 2012 | 50.6% | CN¥702.07 Million | CN¥702.07 Million | CN¥- | CN¥1.39 Billion | ▲ +13.4 pp |
| 2011 | 37.2% | CN¥390.79 Million | CN¥390.79 Million | CN¥- | CN¥1.05 Billion | ▲ +18.2 pp |
| 2010 | 19.0% | CN¥208.23 Million | CN¥208.23 Million | CN¥- | CN¥1.10 Billion | ▲ +5.9 pp |
| 2009 | 13.0% | CN¥120.89 Million | CN¥120.89 Million | CN¥- | CN¥926.88 Million | ▼ -53.9 pp |
| 2008 | 66.9% | CN¥84.02 Million | CN¥84.02 Million | CN¥- | CN¥125.51 Million | ▼ -7.1 pp |
| 2007 | 74.1% | CN¥45.37 Million | CN¥45.37 Million | CN¥- | CN¥61.24 Million | ▼ -119.6 pp |
| 2006 | 193.7% | CN¥41.21 Million | CN¥41.21 Million | CN¥- | CN¥21.28 Million | — |